Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000200299 | SCV000250318 | likely benign | not provided | 2020-09-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088333 | SCV000563021 | likely benign | Congenital contractural arachnodactyly | 2024-12-29 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001818465 | SCV002072404 | uncertain significance | not specified | 2019-03-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003298254 | SCV003997583 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2023-05-01 | criteria provided, single submitter | clinical testing | The p.R270H variant (also known as c.809G>A), located in coding exon 6 of the FBN2 gene, results from a G to A substitution at nucleotide position 809. The arginine at codon 270 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001818465 | SCV004813893 | likely benign | not specified | 2024-02-19 | criteria provided, single submitter | clinical testing |